NCT01525082 2024-02-06Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsStanford UniversityPhase 2 Completed20 enrolled 15 charts
NCT03042780 2020-11-27FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine CarcinomasH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated2 enrolled 6 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT00363051 2013-05-10Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to ChemotherapyNovartisPhase 2 Completed160 enrolled 17 charts
NCT00428597 2010-10-11A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsPfizerPhase 3 Terminated171 enrolled 28 charts